Shire, Teva Call Truce In Fight Over Generic ADHD Drug
A Shire PLC unit said Friday that it had reached a settlement with Teva Pharmaceuticals USA Inc. resolving allegations that Teva infringed two patents for the attention deficit hyperactivity disorder drug...To view the full article, register now.
Already a subscriber? Click here to view full article